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Pattern-Reversal Visual Evoked Potential on Smart
Glasses
Rossana Terracciano, Student Member, IEEE, Alessandro Sanginario, Simona Barbero, Davide Putignano,
Lorenzo Canavese and Danilo Demarchi, Senior Member, IEEE
Abstract—Objective: this work presents an integrated device,
based on smart glasses, for the pattern reversal visual evoked
potential (PR-VEP) clinical test. Methods: smart glasses are
used to generate the checkerboard changing pattern, with its
related red fixation point through an Android® application.
Electroencephalographic signals, for monitoring the stimulus
generated by PR-VEP, were amplified close to the scalp and then
transmitted wirelessly to a PC. A Matlab® real-time algorithm
processed the incoming signals to extract the final PR-VEP signal.
Methods: 40 eyes (from 20 subjects, 12 males and 8 females
between 24–28 years old) were tested and results were compared,
with a commercial device for VEP clinical exam, to test the
reproducibility and the efficacy of the proposed solution. Results:
PR-VEPs generated by smart glasses showed typical triphasic
waveforms: we observed promising results and components in
moderate agreement with those obtained using commercial PR-
VEP recorder, with potential for improvements after further
refinement works. Significance: proposed device leads the way
for a portable and low cost solution.
Index Terms—Visual Evoked Potentials, Android, Smart
Glasses, Wearable, Integrated Medical Devices
I. INTRODUCTION
Visual evoked potentials (VEPs) are an important means for
obtaining reproducible and quantitative data on the function of
the anterior and posterior visual pathways [1]. VEP waveforms
are electrical potentials, caused by repetitive visual stimuli,
which are recorded from the scalp overlying visual cortex [2]
and extracted from the electroencephalogram (EEG) by means
of signal averaging [3].
VEP tests are especially helpful to identify some patholo-
gies, not easily visible through traditional diagnostic tests
[4], that impair the visual pathways in any of its segments
[5]. Therefore, they have been shown to be useful for many
paradigms in cognitive studies (visual attention, working mem-
ory [6], binocular rivalry [7], brain rhythms [8]) and clinical
neuroscience (aging [9], neurodegenerative disorders [10],
schizophrenia [11], optic pathway pathology [12], migraine
[13], autism [14], depression [15], anxiety, stress [16], and
epilepsy [17]). Recently, in engineering, SSVEPs (steady state
visually evoked potentials) found a novel application for
SSVEP-driven braincomputer interface (BCI) systems [18].
Several types of stimuli can elicit VEPs [19], but the most
widely used in clinical practice are flash and pattern stimula-
tions [20]. A flash VEP is obtained when a uniform flash is
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used as stimulus [21], while pattern stimulation corresponds
to the use of reversal of a stimulus (usually a checkerboard or
alternating bars) [20].
Flash-VEPs (morphological model is shown in Figure 1a)
consist of a series of negative and positive waves; the most
predominant are the N2 (90 ms) and P2 (120 ms) peaks [20]
of the detected electroencephalographic signal.
They are extremely variable across different subjects with
respect to pattern responses but show less interocular asym-
metry [22]. In Figure 1b is depicted the morphological model
of a pattern reversal VEP signal (PR-VEP). It consists of a
prominent negative component after a time of about 75 ms
(N75) after signal start, a larger amplitude positive compo-
nent at about 100 ms (P100) and a more variable negative
component at about 135 ms (N135) [20]. PR-VEPs have
the lowest variability in waveform and peak latency across
different subjects [23].
Even though PR-VEPs have been used in clinical and
research laboratories for more than 40 years since Halliday
et al. pioneering work in the early 1970s [24], visual stimuli
are still presented on cathode ray tube (CRT) monitor, plasma
displays and, in recent years, on LCD displays, such as
consumer television or PC monitors, despite some concerns
[25], [26]. Such displays need to be calibrated especially in
their contrast ratio and luminance [27].
The major issues of this equipment are the large size of
the visual stimulator [28] (sometimes screens larger than 40
inches) and the high cost of the devices due to the expensive
apparatus (amplifier and AD board) [29]. Therefore the wide
space required (usually hospitals or clinics use a room exclu-
sively for this type of exam) and the expensiveness pieces of
equipment are drawbacks that have hindered the introduction
of PR-VEPs into routine clinical practice. As a matter of fact,
these factors practically make impossible to execute the exam
outside the clinics or hospitals.
In 2016 a pilot study was conducted comparing a new
PR-VEP stimulation method, based on the use of a head-
mounted display (HMD), with the conventional CRT-based
stimulator with good results [30]. In that work they used
the head mounted-OLED microdisplays SVGA-connected to a
personal computer which generated the stimulation pattern and
recorded PR-VEPs with a commercial device. In this paper we
propose a novel integrate solution to elicit PR-VEP responses
by means of smart-glasses with an AndroidTM application. PR-
VEP signals will be recorded with a low-cost electronics and
will be sent wirelessly to the physician PC. To be an acceptable
alternative to standard PR-VEP exam equipment, a new device
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Fig. 1: Typical morphology of the signal flash VEP (a) and pattern-reversal VEP (b), obtained from a healthy subject from
our own hospital.
should elicits clear PR-VEP responses in their fundamental
components (N75, P100, N135). For this reason, our approach
was compared with a commercial device for PR-VEP exam
(Figure 2).
The main contribution of this paper is the implementation
of a new integrated device with performances comparable
with available commercial instruments, but low cost, portable
and useful for subjects with physical inability to maintain the
upright position or the concentration to the visual fixation.
The remainder of this paper is organized as follows: Section
II describes the proposed PR-VEP recorder prototype and the
details of the performed clinical trial. Experimental setup and
performance of our system, in terms of obtained results, are
presented in Section III. Finally, in Section IV, we conclude
the paper evaluating proposed solution pro, cons and future
works.
II. METHODS
A. Instrumentation
PR-VEP testing was performed in Sperino Ophthalmic
Hospital in Turin, using as a gold standard VEP recorder
the commercial device Retimax Advanced® by CSO [31],
in order to compare results with our prototype. As stated in
[32] Retimax Advanced® function for visual evoked potential
recording follows the ISCEV recommendations.
On the other hand, smart-glasses used to generate the visual
stimulus are the Moverio BT-200® by Epson [33], with a
refresh rate of 60Hz and AndroidTM as the operating system.
To elicit VEP responses the screen that displays the visual
stimulus should have a particular value of luminance and
contrast as indicated by ISCEV standards [20]. Such values
are easily provided by modern LCD screens following some
precautions reported in [34], [35], [27]. A cover for the glasses
was designed and 3D printed to isolate the viewer from the
outside light as shown in Figure 3a.
EEG signal was recorded and sent wirelessly with an
OpenBCI Cyton® board [36] and then PR-VEP waveform was
extracted by a Matlab® real-time algorithm. The OpenBCI
Cyton® board is an 8-channel neural interface with a 32-
bit processor that adopts a Bluetooth Low Energy (BLE)
communication system, sample rate of 250Hz and ADS1299
analog to digital converter. A board holder was designed and
3D printed to be worn from the patient’s arm and to contain all
the electronics (OpenBCI Cyton® board, battery, and audio-
signal amplifier board).
B. Data acquisition
A full-field PR-VEP test was performed using a monocular
stimulus on both eyes of each subject, as recommended in
[20]. We collected 80 PR-VEP signals from a group composed
of 20 people from 24 to 28 years, 12 males and 8 females.
Each subject underwent test using smart glasses and Retimax
Advanced® for both eyes (for a total of 4 measures per
subject: left eye with Retimax, left eye with smart glasses,
right eye with Retimax, right eye with smart glasses). The
orders of presentation were randomized among subjects and
among eyes.
Each subject was selected taking into account that no one
had a history of ophthalmologic diseases and visual acuity was
measured. All the subjects were considered healthy and they
was opportunely refracted with glasses or contact lens, when
needed. They all provided informed consent after receiving
an explanation of study purposes. Table I summarizes the
information about the subjects.
Following 10/20 International Sytem [37], PR-VEP record-
ings were obtained using an active electrode Oz referenced
against mid-frontal electrode Fz. Ground electrode was placed
at A2. Gold cup electrodes were used. Electrode impedance
was kept below 10 kΩ to reduce possible artifacts [20].
PR-VEP using Retimax Advanced® was performed seating
the participant comfortably in a quiet darkened room 1000 mm
from the plasma-TV display. The subject was instructed to
fixate the red fixation point with one eye, while the other eye
was covered with a patch. Subjects were carefully observed
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Fig. 2: Comparison between a traditional PR-VEP test (a) and a smart glasses stimulator-based PR-VEP test (b).
TABLE I: Clinical details of the subjects recruited: subject code, gender, age and distance visual acuity (in terms of Monoyer
chart) was tested with correction (CC), or without correction (SC). If the correction was a contact lens, CL is used as the
identifier.
Subject Code Gender Age (Year) Visual acuity (Left Eye) Visual acuity (Right Eye)
GDL Male 24 10/10, SC 10/10, SC
RT Female 24 10/10, CC, (-2.75D) 10/10, CC (-2.75D)
FR Male 26 10/10, CL (-1.25D) 10/10, CL (-1.25D)
AM Male 24 10/10, SC 10/10, SC
DC Female 26 10/10, CL (-1.75D) 10/10, CL (-1.25D)
SC Female 24 10/10, SC 10/10, SC
MC Male 24 10/10, CL (-1.25D) 10/10, CL (-1.25D)
CP Male 26 10/10, SC 10/10, SC
MCS Male 24 10/10, SC 10/10, SC
GA Male 26 10/10, SC 10/10, SC
TL Female 27 10/10, CC, (-3.25D) 10/10, CC (-3.75D)
MLP Female 25 10/10, CC, (-2.25D) 10/10, CC (-2.75D)
MR Male 24 10/10, CC, (-1.25D) 10/10, CC (-1.25D)
MT Male 25 10/10, CC, (-1.25D) 10/10, CC (-1.25D)
LR Female 24 10/10, CC (-1.75D) 10/10, CL (-1.25D)
SB Female 26 10/10, CC (-1.25D) 10/10, CC (-1.25D)
PDF Female 25 10/10, CL (-2.00D) 10/10, CL (-2.00D)
SM Male 26 10/10, CL (-1.25D) 10/10, CL (-1.25D)
DP Male 28 10/10, SC 10/10, SC
AB Male 25 10/10, SC 10/10, SC
(a) (b)
Fig. 3: Two CAD models were developed: the first one was
customized from the size of the Moverio BT-200 to isolate the
patient from the outside environment (a). The second one was
developed to make wearable the acquisition system (b).
during the procedure and urged to keep fixation in case of
distraction to ensure adequate fixation.
PR-VEP using our prototype each subject also was per-
formed seating the participant comfortably and adjusting the
smart glasses to produce the clearest image. Also in this case
subjects were instructed to fixate the red fixation point at the
center of the image with one eye while the other eye was
covered with a patch. In order to use the smart glasses Moverio
BT-200® as a visual evoked potential stimulator, an AndroidTM
application has been developed. The application lets to set the
stimulation parameters (temporal frequency, spatial frequency)
before performing the test. Moreover, just like with Retimax
Advanced® it is possible to obscure half or a quarter of
the checkerboard if the purpose is to investigate respectively
hemianopsia [38] and quadrantanopia [39] phenomena.
Parameters set used in our experimental protocol were the
same for both systems (Retimax® vs Smart Glasses Prototype)
and they were the following:
• Pattern shape: reversal checkerboard
• Temporal Frequency: 2 reversal per second (RPS)
• Spatial Frequency: 60 minutes of arc
• Aspect Ratio: 16:9
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• Field size: 23◦
• Bandpass filter: 1-100 Hz
• Number of epochs averaged: 100
• Sweeps time: 300 ms
Since the frequencies that can be elicited are limited to
integer divisors of the monitors refresh rate, the AndroidTM
application was functionalized to deliver the stimulus with a
frame-locked reversal frequency. For the clinical trial we used
in both Retimax and Smart glasses case a reversal rate of 2.0
± 0.2 RPS (corresponding to 1.0 ± 0.1 Hz, as written in [20])
and spatial frequency of 60 minute of arc and the contrast was
set to 100% The average response obtained from 100 reversals
artifacts-free was analyzed in each acquisition (every subjects
was tested at least twice to verify VEPs stability, as ISCEV
standard recommends). Ambient light was the same for all
recordings and a very low level of brightness was maintained
in the room.
Stimulation must be synchronized with the acquisition sys-
tem: traditionally, the problem of synchronizing the pattern
shift instant with the triggering of the recording device is
solved by using two ordinary PCs, one for pattern generation
and the other for signal recording [40] or using PC with a very
fast video processor (and this is the way adopted in Retimax®
device). Basically, in our prototype user starts the stimulation
directly through the Epson® trackpad: as soon as the smart
glasses display the patterned stimulation, a trigger, in the form
of a sound impulse, is generated. Through an audio jack and
an amplifier circuit, the trigger signal is propagated to a GPIO
pin of the OpenBCI Cyton® board. This event starts the EEG
recording. Such simple solution is effective in synchronizing
the two events as it is shown in the following section.
The extraction of the PR-VEP using smart glasses from the
EEG signal was performed by a Matlab® real-time algorithm
that implements a 5th order IIR bandpass filter in the 1 Hz-
100 Hz band without any notch filters as ISCEV standards
require. Nevertheless, as we are approaching to a new device,
we studied the effect of a notch filter in data analysis finding
no evident morphology change in the extracted waveforms.
Additional details can be found in Supplementary Information
document.
According to the ISCEV standards [20], signal was sampled
from 0 to 300 ms after stimulus. In order to eliminate blinking
artifacts, all epochs with a signal exceeding a threshold of
± 35 µV are discarded from the average. The number of the
discarded is comparable between the two methods, because in
both case it is in the range of 0-25 discarded epochs. It wasn’t
found any dependence from the system used about discarding
the epochs. The averaging method is based on the assumption
that the noisy EEG activity are uncorrelated with the VEP
waveform, thus calculating the average, the noise decreases
by a factor of 1/
√
N , where N is the number of averaged
epochs. The synchronized (time-locked) averaging is essential
to separate the buried evoked potential waveforms from other
activity [41].
A recurring issue in this kind of experiment is the defocus-
ing in monocular vision into the smart glasses because it could
produce an eyestrain during the test. This problem has been
partially solved by accustoming for the first time the subject
to the binocular vision into the glasses. In any case, each test
was conducted at a very low frequency also to avoid epileptic
phenomena.
C. Data processing
Data processing for statistical analysis was performed with
Matlab®. For each waveform 10 features regarding tripha-
sic depolarization in terms of latency and amplitude were
extracted automatically using a Matlab algorithm that finds
peaks (minimum and maximum) in a time range, in which
PR-VEP signal is expected, after the stimulus. Another feature
extracted is the absolute power density (µV 2/Hz) to retrieve
information from the frequency domain analysis (performed
using the fast Fourier transform algorithm, with the resolution
of 3.33 Hz).
The final goal of this analysis is to compare outputs pro-
duced by our prototype with those taken from a commercial
device. For this reason, extracted dataset was analyzed to
determine the difference in terms of latencies and amplitudes
of responses between two different stimuli.
In order to analyze statistically the agreement between the
two different stimulators, extracted data were plotted with a
Bland-Altman, scatter-plots and boxplots. Finally, Pearson’s
correlation coefficient was estimated in order to understand
if the relationship between the variables is linear or not,
and the concordance correlation coefficient was computed for
evaluating the reproducibility.
III. RESULTS AND DISCUSSION
Resulting averaged features extracted from the 20 subjects
are reported in Table II. Regarding the morphology of the
signals, as it is shown in Figure 4, PR-VEP of each stimulus
showed typical triphasic waveforms characterized by three
dominant peaks of N75, P100, and N135. It is clearly no-
ticeable that the morphology are comparable even though
there are some differences in amplitude and latency. PR-VEP
amplitudes from Retimax Advanced® were reasonably greater
than those from smart glasses. On the other hand, N75, P100
and N135 latencies from Retimax Advanced® were strongly
similar to those evoked with smart glasses, but slightly wider
than those evoked with smart glasses. No meaningful right to
left side difference in latency or amplitude was observed for
both methods.
Regarding frequency domain analysis, the PR-VEPs evoked
with the Retimax Advanced® seem to provide a higher infor-
mation content about power density than the smart glasses
PR-VEPs. We choose to use also the boxplots to compare and
to analyze the features. Supplementary Information document
provides a more complete picture of the data and allows to
visualize differences among the two methods to evoke visual
potentials. Except for the case of the N75 latency in the left
eye, the ranges are comparable within the two methods in
all the other cases. In fact, very strong similar values of the
median are shown in the cases of amplitudes and relative
amplitude and P100 latency.
In Figure 5, the correlation between Retimax and smart
glasses data and the Bland-Altman plots are reported for the
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TABLE II: Features results table: differences between Retimax and smart glasses stimulation in terms of PR-VEP latencies,
amplitudes and power. Values are presented as mean± standard deviation.
Left Eye Right Eye Right To Left Differences
Retimax Smart
Glasses
Absolute
Mean
difference
Retimax Smart
Glasses
Absolute
Mean
difference
Retimax Smart
Glasses
Absolute
Mean
difference
Amplitude (µV)
N75 Amplitude -2.05 ±
1.65
-2.48 ±
1.27
0.43 -2.54
±1.70
-2.71 ±
1.26
0.17 0.48±
0.98
0.23 ±
0.68
0.25
P100 Amplitude 10.99 ±
2.98
8.67 ±
3.14
2.31 10.73 ±
2.75
8.99 ±
3.18
1.74 1.31 ±
0.97
0.32±
1.02
0.07
N135 Amplitude -3.12 ±
1.95
-3.64 ±
1.35
0.52 -3.62 ±
1.45
-3.56 ±
1.51
06 0.50 ±
0.77
0.07 ±
0.54
0.42
N75-P100 Amplitude 13.04
±3.88
11.15 ±
3.72
1.88 13.27 ±
4.22
11.71 ±
3.89
1.56 0.23 ±
1.63
0.55 ±
1.23
0.32
P100-N135 Amplitude 14.11±
4.16
12.31 ±
4.19
1.79 14.36 ±
3.88
12.56 ±
4.36
1.80 0.32 ±
1.41
0.24 ±
1.21
0.01
Latency (ms)
N75 Time Peak 64.4 ±
8.59
57.2 ±
5.96
7.2 68.6 ±
7.48
58.8 ±
7.00
9.80 4.2 ±
8.13
1.60±
6.34
2.6
P100 Time Peak 106.4 ±
4.18
103.8 ±
10.73
2.6 106.4 ±
4.56
104.2 ±
8.84
2.2 0 ± 2.39 0.4± 5.94 0.4
N135 Time Peak 167.4 ±
14.52
164.4 ±
9.87
3 159.4 ±
12.60
168.8 ±
10.43
9.40 8± 12.27 4.4 ±
7.29
3.6
N75-P100 Time Peak 42 ±
10.5
46.6 ±
10.56
64.6 37.8 ±
10.5
45.4 ±
9.10
7.6 4.2± 8.63 1.2 ±
6.16
3
P100-N135 Time Peak 61 ±
15.78
60.6 ±
8.63
0.4 53 ±
10.92
64.6 ±
10.56
11.60 8 ±
11.79
4 ± 7.74 4
Frequency Domain (µV 2/Hz)
Power Density 11.48 ±
2.68
9.12 ±
2.36
2.92 11.77 ±
2.68
9.14 ±
2.63
1.82 0.70 ±
0.65
2.25 ±
1.09
1.55
most significant features: P100 amplitude, P100 latency, and
power density. Linear regression analysis allows to evaluate
the constant (intercept) and proportional (slope) systematic
error: in particular it is possible to notice the presence of a
constant systematic error (especially in case of P100 latency
component), instead a very slight proportional systematic error
(slope is less than 1) is detected.
The Bland-Altman plots were used to easily compare the
two measurement systems. In the case of the P100 amplitude,
no dependence between the differences and the mean values
are noted: the points cluster randomly around the average
line of the differences. It is possible to see the presence of
a bias (-28% for left eyes, p-value<<0.01, and -21% for right
eyes, p-value<<0.01): 95% of the differences between the two
methods is in the range between -86% and 30% for the P100
amplitude of the left eyes and between -83% and 40% for the
P100 amplitude of the right eyes.
In the case of the P100 latency feature, smart glasses method
produces, on average, lower results than the Retimax method
for low latency levels. In this case, the bias is very small (-
2.9% for left eyes, p-value> 0.01, and -2.3% for right eyes,
p-value> 0.01 ) and 95% of the differences between the two
methods is in the range within -19% and 13%, and -17%
and 13% respectively. Such latency differences are still too
high for a proper diagnosis instrument. The ways through
which they can be reduced are mainly two: from one side it is
necessary to increase the sampling frequency of the acquisition
board to obtain a better resolution and to implement the 1-100
Hz band-pass filter with hardware components. On the other
hand, a larger set of subjects need to be tested to refine the
measurement differences.
Also in the case of the power density, no dependence of
the differences are noted from the mean values, as the points
cluster randomly around the average line of differences. A
small bias (at -27% for left eyes, p-value<<0.01, and -24% for
right eyes, p-value<<0.01) is evident: 95% of the differences
between the two methods is in the range between -64% and
11% for the power density of the left eyes and between -55%
and 12% for the power density of the right eyes.
Finally, evaluation of the correlation and the agreement be-
tween the two techniques is shown in Table III. The most sta-
ble component of PR-VEP signal is the P100. The agreement
between the two techniques is therefore satisfying (p<0.05)
both in the left eye (respectively CCC=0.55, ICC=0.21, preci-
sion=0.71, accuracy=0.77 for the P100 amplitude) and in the
right eye (respectively CCC=0.47, ICC=0.13, precision=0.56,
accuracy=0.84 for the P100 amplitude). We can affirm that
the two systems results have significant congruence according
to both methods of comparison (linear regression and Bland-
Altman plots). As stated in International Federation of Clini-
cal Neurophysiology recommendations for visual systems [42],
the physiological properties of the triphasic components of
2168-2194 (c) 2018 IEEE. Personal use is permitted, but republication/redistribution requires IEEE permission. See http://www.ieee.org/publications_standards/publications/rights/index.html for more information.
This article has been accepted for publication in a future issue of this journal, but has not been fully edited. Content may change prior to final publication. Citation information: DOI 10.1109/JBHI.2019.2899774, IEEE Journal of
Biomedical and Health Informatics
6
0 0.05 0.1 0.15 0.2 0.25
-4
-2
0
2
4
6
8
10
12
14 95% confidence boundaries
PR-VEP Retimax
(a)
0 0.05 0.1 0.15 0.2 0.25
-4
-2
0
2
4
6
8
10
12
14 95% confidence boundaries
PR-VEP Smart Glasses
(b)
Fig. 4: All the PR-VEP waveforms obtained during the test using: the Retimax stimulator (a) and the smart glasses (b). The
PR-VEPs obtained in both cases showed very similar potentials, well-defined in terms of N75, P100, and N135 components.
PR-VEPs differ between subject depending on age, sex and
pupil size, affecting both amplitude and latency. For example,
females have been shown to have slightly shorter P100 latency,
as resulted in [23], and larger P100 amplitude than males.
Furthermore, P100 amplitude tends to decrease with a small
diameter pupil while the latency of P100 increases. As written
in [43], despite the synchronization between the stimulus and
the evoked potential, the latency-components are not always
constant and can be affected by different kinds of factors,
for example, the physiological latency between the stimulus
perception and the PR-VEP, sometimes depends on the cur-
rent cerebral workload (i.e. several tenths of milliseconds).
Consequently, it is clear that high jitter values can significantly
influence the amplitude of the PR-VEP due to the average. A
possible solution, would be the use of realignment algorithm as
done in [44], where authors compared latency-jitter correction
methods with standard averaging, finding an improved P100
amplitude. It has to be noted though, that such realignment-
based method are not supported by ISCEV regulations for
standard clinical visual evoked potentials.
In this study was found an electronic jitter of 28±8 ms,
deleted automatically before acquisitions. No assumption, in-
stead, was done for the physiological jitter, as the ISCEV
regulations state.
IV. CONCLUSION
We proposed an integrated, portable and low cost solution
for pattern reversal visual evoked potential tests. The system
is able to generate visual stimuli such as (but not limited
to) the commonly used checkerboard, with the possibility to
choose different parameters (e.g. spatial and/or temporal fre-
quency). The resulting PR-VEPs are acquired synchronously
by a commercial EEG acquisition board following the 10/20
International System [37]. Data is then sent to a laptop via
bluetooth connection and processed real-time with Matlab®.
Results of our system are compared with a commercial
PR-VEPs exam device and show a very strong similarity.
Waveforms amplitudes are slight lower in comparison with
the Retimax® ones, instead latency differences lies inside a
10% range. These differences are still improvable but they are
enough for the purpose of the evaluation of a good propagation
of the signal through the optic pathway pathology.
The advantages that derived from our device are several.
Its portability can enable PR-VEPs exams at the patient’s
home. Moreover, the exam could be executed also to bedridden
or movement impaired patients but in this regards additional
studies may be necessary. Also, the cost of this prototype,
considering only the bare components (smart glasses, Cyton
board, 3D printed fixture and minor analog electrical compo-
nents) is less than 1300 EUR. This indicates that the final price
in case of commercialization would be sensibly less than the
cost of current VEP analysis equipment (around 20000 Euros).
However, several limitations of this study should be dis-
cussed. First of all, the smaller sample size, due to the limited
number of participants; the proof of concept in this study
was to demonstrate the possibility to evoke visual potential
with smart glasses, anyway, larger dataset should be useful to
understand how to improve the measure. In this sense, also the
gender distribution and age range should be extended. In fact,
as recommended in IFCN recommendations for visual system
testing [42] should be useful for each laboratory to establish
their own normative values for each decade from the age of 15
years onwards. Another point to discuss is that although the
test was monitored closely by an experienced ophthalmologist,
it was not possible to monitoring directly the visual fixation.
In fact, when the acquisition was conducted with Retimax
Advanced® and the TV display, doctors monitored constantly
the subjects and urged them to concentrate on their visual
task. In the case of the test conducted with the smart glasses,
visually monitoring the stability of the fixation was impossible:
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Fig. 5: Scatter plots and Bland-Altman plots obtained in this study for: the P100 Amplitude (a left eye, b right eye), the P100
Latency (c left eye, d right eye) and the Power Density (e left eye, f right eye) data extracted from the signals. As additional
information on the correlation are reported: the number of the data points used (n), the Pearson r-value (r), The Pearson r-value
squared (r2), and finally the slope/interception equation. On the other hand, as additional information on the Bland-Altman
plots are reported: the reproducibility coefficient (RCP, at 95% confidence level), and coefficient of variation (CV, expressed
as standard deviation of mean values in %).
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TABLE III: Evaluation of the correlation and the agreement between the two techniques: concordance correlation coefficient
(CCC), Pearson correlation coefficient (precision), bias correction factor (χb, accuracy) and intraclass correlation coefficient
(ICC) was computed at 95% confidence interval.
Right Eye Left Eye
CCC Pearson
ρ (pre-
cision)
χb (ac-
curacy)
p-value ICC CCC Pearson
ρ (pre-
cision)
χb (ac-
curacy)
p-value ICC
Amplitude (µV)
N75 Amplitude 0.06 0.06 0.95 0.71 -0.04 -0.28 0.30 0.93 0.36 -0.02
P100 Amplitude 0.47 0.56 0.84 0.07 0.13 0.55 0.71 0.77 0.02 0.21
N135 Amplitude 0.38 0.38 0.99 0.89 -0.03 0.46 0.52 0.89 0.33 0.02
N75-P100 Amplitude 0.48 0.52 0.92 0.02 0.04 0.51 0.57 0.89 0.12 0.09
P100-N135 Amplitude 0.51 0.56 0.90 0.17 0.06 0.67 0.74 0.91 0.18 0.07
Latency (ms)
N75 Time Peak 0.08 0.15 0.52 <0.01 0.46 -0.10 -0.15 0.63 <0.01 0.29
P100 Time Peak 0.34 0.44 0.77 0.34 0.01 0.39 0.61 0.64 0.32 0.02
N135 Time Peak 0.05 0.07 0.74 0.01 0.22 -0.15 -0.16 0.90 0.45 -0.02
N75-P100 Time Peak 0.52 0.68 0.76 0.02 0.22 0.37 0.40 0.91 0.18 0.06
P100-N135 Time Peak -0.10 -0.15 0.63 <0.01 0.34 -0.09 -0.01 0.84 0.92 -0.05
Frequency Domain (µV 2/Hz)
Power Density 0.54 0.75 0.70 <0.01 0.28 0.52 0.78 0.66 <0.01 0.34
the eye tested, in fact, was completely covered both by the
lens of the glasses and by the 3D printed cover to reduce
the external stimuli coming from the background. To mitigate
the problem, the operator constantly repeated to maintain the
concentration. Moreover, one of the advantage of the head
mounted display is the fact that the subject is less prone
to distractions because his vision is strictly confined to the
mini-display. To overcome this issue an eyeball monitoring
system will be integrated in the 3D printed cover. Latencies
of smart glasses are slightly different from those recorded with
the Retimax Advanced®, this is probably due to the relatively
low sampling frequency of the acquisition board that will be
increased in the future to improve time measurements.
In addition to discussed issues, future work needs to include
a way to induce flash-VEPs and future studies on intra-
subject and inter-session reliability are desirable to proof the
clinical usefulness of the proposed device. Above all, the
most important work to be done, is the test of our device
on pathologic subjects to evaluate the evoked response. This
pilot study was conducted on healthy subjects for the device
setup and development, but an informal agreement with the
hospital will soon lead to more challenging study of abnormal
PR-VEP detection.
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